John L. Higgins - Dec 28, 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
/s/ Andrew Reardon, Attorney-in-Fact for John L. Higgins
Stock symbol
LGND
Transactions as of
Dec 28, 2022
Transactions value $
-$350,608
Form type
4
Date filed
12/30/2022, 04:00 PM
Previous filing
Dec 27, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$351K -5.29K -1.25% $66.29 418K Dec 28, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.